Thoroughbred Financial Services, LLC Exact Sciences Corp Transaction History

Thoroughbred Financial Services, LLC

  • $1.55 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022
SELL
$72.5 - $100.68 $155,222 - $215,555
-2,141 Closed
0 $0
Q3 2021

Oct 27, 2021
SELL
$90.24 - $124.05 $71,199 - $97,875
-789 Reduced 26.93%
2,141 $204,000
Q2 2021

Jul 27, 2021
BUY
$93.66 - $139.27 $5,713 - $8,495
61 Added 2.13%
2,930 $364,000
Q1 2021

Apr 30, 2021
BUY
$116.57 - $155.01 $137,319 - $182,601
1,178 Added 69.66%
2,869 $378,000
Q4 2020

Jan 26, 2021
BUY
$99.61 - $142.12 $168,440 - $240,324
1,691 New
1,691 $224,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Thoroughbred Financial Services, LLC Portfolio

Follow Thoroughbred Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email